eef2k inhibitor (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
eef2k inhibitor
Eef2k Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eef2k/A-484954/pm41619002-52-5-20
Average 94 stars, based on 7 article reviews
Eef2k Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eef2k/A-484954/pm41619002-52-5-20
Average 94 stars, based on 7 article reviews
eef2k inhibitor - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
other:Article Title: Emodin inhibits Newcastle disease virus replication via regulating the phosphorylation levels of eEF2K/eEF2 and targeting viral N protein to reduce viral protein production. Article Snippet: The chemical compounds NH125 and Article Title: IL-6 translation is a therapeutic target of human cytokine release syndrome. Article Snippet: Chimeric antigen receptor (CAR) T therapies have achieved remarkable success for treating hematologic malignancies, yet are often accompanied by severe cytokine release syndrome (CRS).. Here, an accidental clinical observation raised the possibility that metoprolol, an FDA-approved β1 adrenergic receptor blocker widely used for cardiovascular conditions, may alleviate CAR T–induced CRS.. Metoprolol effectively blocked IL-6 production in human monocytes through unexpected mechanisms of action of targeting IL-6 protein translation but not IL6 mRNA expression. Article Title: DR5 disulfide bonding as a sensor and effector of protein folding stress Article Snippet: Reagents were purchased from the following companies: Tunicamycin and Chloroquine: Sigma-Aldrich (St. Louis, MO); Thapsigargin: AdipoGen (San Diego, CA); Lapatinib: Selleck Chemicals (Houston, TX); Doxycycline: Enzo Life Science (Farmingdale, NY); TORIN1, and dithiothreitol (DTT): TOCRIS Bioscience (Minneapolis, MN); Cyclosporine A (CsA): Biorbyt (Duran, NC); Rapamycin and PERK Inhibitor I (GSK2656157): Calbiochem (Burlington, Massachusetts); Bafilomycin A1, Gefitinib, ISRIB, MK2206, and Q-VD-OPH: Cayman Chemical (Ann Arbor, MI); N -ethylmaleimide (NEM): Thermo Fisher Scientific (Grand Island, NY); Article Title: Conditional deletion of TRPC1 channel modulates synaptic plasticity, long term depression, and memory extinction in Fragile X syndrome mice Article Snippet: A-484954 , Article Title: Conditional deletion of TRPC1 channel modulates synaptic plasticity, long term depression, and memory extinction in Fragile X syndrome mice Article Snippet: CCK-8 Assay:Article Title: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells. Article Snippet: 1 Department of Oncology, Xianyang Central Hospital, No. 78, Renmin East Road, Weicheng District, Xianyang 712000, Shaanxi Province, China 2 Clinical Medicine College, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China 3 Key laboratory of the Jiangsu Higher Education Institutions for Integrated Traditional Chinese and Western Medicine in Senile Diseases Control, Faculty of Medicine, Yangzhou University, No.88, South University Road, Yangzhou 225001, Jiangsu Province, China Abstract Background The phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway is closely associated with the development and progression of lung cancer.. Buparlisib (BKM-120), a selective PI3K inhibitor, represents a novel potential therapeutic strategy for lung cancer.. However, the reason for its limited initial efficacy as a monotherapy remains poorly understood. |